Re: A problem in hospitals

BrentB wrote:
Mark Probert wrote:
BrentB wrote:
Vernon wrote:
Don't tell anyone, but, two major, multi-location hospitals are feeding
patients a multi-vitamin tablet every day after the first day.

It MUST be a conspiracy of some sort.
I've heard in Germany some hospitals are using IV ascorbic acid. Very
hush hush about it.
Not to mention what are the VA hospitals doing with all that c silver
they purchased...hmmm.

Back to that yarn? First, you have yet to show exactly how much they
have purchased.

Second, the evidence that I posted previously (look it up) showed that
they are using it as a topical anti-bacterial. No one disputes that this
is a valid use.

Maybe you can help me. instead of going over old arguments I thought
I'd check out pubmed. Question. If we have a product such as the one
below that stops the epidemic of MRSA why is it not in any mass media
publications or news outlet? An epidemic and a solution yet no one
knows about either...strange, don't you think?

Epidemic? Not exactly.

What makes you believe that there are no silver based dressings?


Antimicrobial and barrier effects of silver against
methicillin-resistant Staphylococcus aureus.

* Edwards-Jones V.

Research Development Unit, St Augustine's, Manchester Metropolitan
University, Manchester, UK. v.e.jones@xxxxxxxxx

OBJECTIVE: Two strains of methicillin-resistant Staphylococcus
aureus (MRSA), termed epidemic strains (EMRSA-15 and EMRSA-16), were
used to evaluate the antimicrobial and barrier effect of four silver
dressings (two silver donating and two non-silver-donating) available
in the UK at the time of the study. METHOD: The moist surface of a
blood agar plate was covered with 10(6) colony-forming units of the
respective strain of MRSA, and dressings were applied to the surface
and incubated at 37 degrees C for different time periods and the upper
and lower surfaces subcultured for residual growth. RESULTS: The
nanocrystalline dressings (silver donating) were effective as a barrier
from one hour until the study end (72 hours): no penetration of
EMRSA-15 and EMRSA-16 through the dressing occurred. Moreover, the
nanocrystalline dressings showed some antimicrobial activity at one
hour in the areas underneath and surrounding the dressing until the
study end. The remaining two dressings had no barrier effect and only
demonstrated limited antimicrobial activity after 24 hours. CONCLUSION:
This in vitro study suggests that the nanocrystalline dressings are
more effective than other silver dressings in terms of providing a
barrier function and antimicrobial activity against EMRSA-15 and
EMRSA-16.

PMID: 16869194 [PubMed - in process]

.

Relevant Pages

  • Re: A problem in hospitals
    ... Not to mention what are the VA hospitals doing with all that c silver ... dressings available ... EMRSA-15 and EMRSA-16 through the dressing occurred. ... The remaining two dressings had no barrier effect and only ...
    (misc.health.alternative)
  • Re: History of Silver in Medicine
    ... History of Silver in Medicine and Wound Dressings ... dressings** for wounds. ... studied the effect of electrically activated silver-coated fabrics on ...
    (misc.health.alternative)